ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,253, issued on Sept. 9, was assigned to aTyr Pharma Inc. (San Diego).
"Compositions comprising anti-NRP2 antibodies" was invented by Luke Burman (San Diego), Yeeting Chong (San Diego), Leslie Ann Greene (San Diego), David King (Encinitas, Calif.), Zhiwen Xu (La Jolla, Calif.) and Ryan Andrew Adams (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are affinity matured and humanized antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, and which thereby modulate subsequent NR...